Modulatory role of prolactin in type 1 diabetes.

Edgar G Ramos MartínezIvan Ramos-MartínezJorge ValenciaJuan Carlos Ramos-MartínezLuis Hernández-ZimbrónAnaiza Rico-LunaEduardo Pérez-CamposLaura Pérez-Campos MayoralMarco Cerbón

Published in: Hormone molecular biology and clinical investigation (2022)

Prolactin treatment appears to be a promising strategy to improve beta-cell vascularization and proliferation in transplantation and immunotherapies.

Keyphrases

type diabetes
cell therapy
single cell
signaling pathway
cardiovascular disease
glycemic control
stem cells
insulin resistance